Herald Scholarly Open Access, is a publishing platform that publishes articles in the Open Access model, which aids the readers and researchers to view, download, share, disseminate and print any article without a subscription. We believe that the articles submitted to Herald Scholarly Open Access Journals will be under open access model.
In the Open Access model, we process the article with strict double-blind peer review process under the editorial board supervision. After the process completion, an invoice will be raised for the author to publish the manuscript. The charges will be applicable only for accepted articles. There is no separate charge for submission of the manuscript.
Authors are encouraged to publish their work with us and we don’t wish the publication charges will become a barrier for the authors who are unable to pay. For those authors, we provide a range of waiver or discounts in the publication charges. In order to provide these discounts and waiver, we follow the World Bank Country Classification.
The authors, who receive support and funding for their work will be asked to pay the full charges and are not liable for the discounts. The publication charges of the respective journals are given below:
|Journal||ISSN||Publication Charges (USD)|
|Addiction & Addictive Disorders||2378-9042||925|
|AIDS Clinical Research & STDs (ACRS)||2572-7370||1375|
|Alcoholism, Drug Abuse & Substance Dependence(ADSD)||925|
|Allergy Disorders & Therapy (ADT)||2470-749X||925|
|Alternative, Complementary & Integrative Medicine(ACIM)||2470-7562||1375|
|Alzheimer's & Neurodegenerative Diseases(AND)||2572-9608||1150|
|Anesthesia & Clinical care (ACC)||2378-8879||1375|
|Angiology & Vascular Surgery (AVS)||2572-7397||925|
|Animal Research & Veterinary Science(ARVS)||1150|
|Atmospheric & Earth-Sciences (AES)||1150|
|Aquaculture & Fisheries||1150|
|Virology & Antivirals(VA)||925|
|Cancer Biology & Treatment (CBT)||2470-7546||1375|
|Cardiology & Neurocardiovascular Diseases(CNCD)||2378-8860||925|
|Cell Biology & Cell Metabolism (CBCM)||2381-1943||1375|
|Clinical Dermatology & Therapy (CDT)||2378-8771||1375|
|Clinical Immunology & Immunotherapy (CIIT)||2378-8844||1375|
|Clinical Studies & Medical Case Reports (CSMC)||2378-8801||925|
|Community Medicine & Public Health Care (CMPHC)||2381-1978||1375|
|Cytology & Tissue Biology (CTB)||2378-9107||1375|
|Dentistry: Oral Health & Cosmesis(DOHC)||2473-6783||925|
|Diabetes & Metabolic Disorders (DMD)||2381-201X||1150|
|Emergency Medicine Trauma & Surgical Care (ETS)||2378-8798||1150|
|Food Science & Nutrition (FSN)||2470-1076||1375|
|Forensic, Legal & Investigative Sciences (FLIS)||2473-733X||1375|
|Gastroenterology & Hepatology Research(GHR)||1150|
|Internal Medicine & Primary Healthcare||925|
|Gerontology & Geriatric Medicine(GGM)||2381-8662||1375|
|Hematology, Blood Transfusion & Disorders (HBTD)||925|
|Human Endocrinology (HE)||925|
|Genetics & Genomic Sciences (GGS)||925|
|Infectious & Non Infectious Diseases (INID)||2381-8654||1150|
|Laser-Research & Applications (LRA)||1150|
|Microbial Pathophysiology & Pathogenesis (MPP)||925|
|Neonatology & Clinical Pediatrics (NCP)||2378-878X||1150|
|Nephrology & Renal Therapy(NRT)||2473-7313||1150|
|Nuclear Medicine, Radiology & Radiation Therapy(NMRR)||2572-7419||925|
|Obesity & Weight Loss(OWL)||2473-7372||925|
|Ophthalmology & Clinical Research (OCR)||2378-8887||1375|
|Orthopedic Research & Physiotherapy (ORP)||2381-2052||1375|
|Otolaryngology, Head & Neck Surgery(OHNS)||2573-010X||1375|
|Pharmacology Research & Therapeutics(PRT)||650|
|Pharmaceutics, Drug Delivery & Safety(PDDS)||650|
|Physical Medicine, Rehabilitation & Disabilities(PMRD)||2381-8670||1375|
|Psychiatry, Depression & Anxiety(PDA)||1150|
|Pulmonary Medicine & Respiratory Research(PMRR)||1375|
|Practical & Professional-Nursing(PPN)||1150|
|Reproductive Medicine, Gynaecology & Obstetrics (RMGO)||1150|
|Stem Cells Research, Development & Therapy(SRDT)||2381-2060||1150|
|Vaccines Research & Vaccination(VRV)||925|
Manuscript with drawl policy:
Herald Scholarly Open Access is an international online open access publishing house which aims to publish high-quality articles with strict processing. We anticipate the authors to follow the publications ethics in the article quality management and support the Journal.
Some authors will withdraw the manuscript right after the submission, or during the publication process or after publishing. The precious time of editors, reviewers and editorial staff which are used for the manuscript processing will become purposeless. So we request the authors to check carefully prior the submission and proceed with the submission. With drawl of the manuscript is only allowed in unavoidable situations.
Article with drawl will be confirmed only by submitting a letter of with drawl to the editorial office with the signatures of all the authors and need to get confirmation from the editorial office.
If the author paid the charges and then withdrawn the article after publishing, then the charges which are already paid is not refunded.
Unethical with drawl is not acceptable by the Journal. If the authors appeal for with drawl right after submission or during peer review process or at the end of processing or after the completion of processing (If the article is given a pdf number and DOI), they need to pay penalty for with drawl.
Herald Scholarly Open Access announces with drawl charges are applicable.